Virus persistence and recrudescence after Ebola virus disease: what are the risks to healthcare workers?

Journal of Hospital Infection

Volumn 94, Issue 2, 2016, Pages 113-115

  MacDermott, N E ^a   Bausch, D G ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

CLINICAL FEATURE; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EDITORIAL; EPIDEMIC; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH HAZARD; HUMAN; INFECTION RISK; MORTALITY RATE; NONHUMAN; OCCUPATIONAL HEALTH; OCCUPATIONAL SAFETY; PERSISTENT VIRUS INFECTION; PRACTICE GUIDELINE; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYMPTOMATOLOGY; VIRUS SHEDDING; BODY FLUID; DISEASE TRANSMISSION; ISOLATION AND PURIFICATION; RECURRENT DISEASE; RISK ASSESSMENT; TIME FACTOR; TRANSMISSION; VIROLOGY;

BODY FLUIDS; EBOLAVIRUS; HEALTH PERSONNEL; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; RECURRENCE; RISK ASSESSMENT; TIME FACTORS;

EID: 84994275431     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2016.07.004     Document Type: Editorial

References (18)

1. 1 Rowe, A.K., Bertolli, J., Khan, A.S., et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179:Suppl. 1 (1999), S28–S35.
2. 2 Clark, D.V., Kibuuka, H., Millard, M., et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis 15 (2015), 905–912.
3. 3 Mattia, J.G., Chang, J.C., Platt, D.E., et al. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis 16 (2015), 331–338.
4. 4 Vetter, P., Kaiser, L., Schibler, M., Ciglenecki, I., Bausch, D.G., Sequelae of Ebola virus disease: the emergency within the emergency. Lancet Infect Dis 16 (2016), e82–e91.
5. 5 Nelson, J.M., Griese, S.E., Goodman, A.B., Peacock, G., Live neonates born to mothers with Ebola virus disease: a review of the literature. J Perinatol 36 (2015), 411–414.
6. 6 Bower, H., Grass, J.E., Veltus, E., et al. Delivery of an Ebola virus-positive stillborn infant in a rural community health center, Sierra Leone, January 2015. Am J Trop Med Hyg 94 (2016), 417–419.
7. 7 Varkey, J.B., Shantha, J.G., Crozier, I., et al. Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med 372 (2015), 2423–2427.
8. 8 Jacobs, M., Rodger, A., Bell, D.J., et al. Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet, 2016, 10.1016/S0140-6736(16)30386-5 [Epub ahead of print].
9. 9 Christie, A., Davies-Wayne, G.J., Cordier-Lasalle, T., et al. Possible sexual transmission of Ebola virus – Liberia, 2015. MMWR Morbid Mortal Wkly Rep 64 (2015), 479–481.
10. 10 Mate, S.E., Kugelman, J.R., Nyenswah, T.G., et al. Molecular evidence of sexual transmission of Ebola virus. New Engl J Med 373 (2015), 2448–2454.
11. 11 Green, E., Hunt, L., Ross, J.C., et al. Viraemia and Ebola virus secretion in survivors of Ebola virus disease in Sierra Leone: a cross-sectional cohort study. Lancet Infect Dis, 2016, 10.1016/S1473-3099(16)30060-3 [Epub ahead of print].
12. 12 Harries, J., Jacobs, M., Davies, S.C., Ebola survivors: not out of the woods yet. BMJ, 532, 2016, i178.
13. 13 World Health Organization, Interim infection prevention and control guidance for care of patients with suspected or confirmed filovirus haemorrhagic fever in health-care settings, with focus on Ebola. 2015, WHO, Geneva Available at: http://apps.who.int/iris/bitstream/10665/130596/1/WHO_HIS_SDS_2014.4_eng.pdf?ua=1&ua=1&ua=1 [last accessed May 2016].
14. 14 World Health Organization, Personal protective equipment in the context of filovirus disease outbreak response. 2014, WHO, Geneva Available at: http://apps.who.int/iris/bitstream/10665/137410/1/WHO_EVD_Guidance_PPE_14.1_eng.pdf?ua=1 [last accessed May 2016].
15. 15 Jacobs, M., Aarons, E., Bhagani, S., et al. Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers. Lancet Infect Dis 15 (2015), 1300–1304.
16. 16 World Health Organization, Clinical care for survivors of Ebola virus disease. Interim guidance. 2016, WHO, Geneva Available at: http://apps.who.int/csr/resources/publications/ebola/guidance-survivors/en/index.html [last accessed January 2016].
17. 17 Blackley, D.J., Lindblade, K.A., Kateh, F., et al. Rapid intervention to reduce Ebola transmission in a remote village – Gbarpolu County, Liberia, 2014. MMWR Morbid Mortal Wkly Rep 64 (2015), 175–178.
18. 18 National Institutes of Health, Study of Ebola survivors opens in Liberia. 2015, NIH, Bethesda, MD Available at: http://www.nih.gov/news-events/news-releases/study-ebola-survivors-opens-liberia [last accessed April 2016].